Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

Nicola Fazio, Roberto Biffi, Giuseppe Curigliano, Katia Lorizzo, Maria Giulia Zampino, Filippo de Braud, Antonio Chiappa, Arnaud Roth, Aron Goldhirsch

Journal: Journal of the National Cancer Institute 2007;99(17):1345-6; author reply 1346-7

PMID: 17728219

Abstract

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.